Size and Share of Healthcare Marketing Services

Healthcare Marketing Services Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Analysis of Healthcare Marketing Services by Mordor Intelligence

The healthcare marketing services market size is projected to expand from USD 53.73 billion in 2025 to USD 56.82 billion in 2026, and to USD 79.81 billion by 2031, registering a CAGR of 7.03% between 2026 and 2031. Patient decisions increasingly begin with online search, social platforms, and AI tools, which move marketing work closer to patient access and care navigation. Marketing providers are also being asked to connect campaign activity with appointment booking, adherence, and measurable patient outcomes. Privacy rules are raising the value of compliant data collection, consent management, and measurement systems. Generative AI is reducing the time needed for routine content work, while increasing demand for clinically reviewed content, visibility in AI-generated answers, and stronger evidence for marketing investment. The healthcare marketing services market, therefore, favors firms that can combine communications capabilities with compliant technology and healthcare-specific expertise.

Key Report Takeaways

  • By service type, digital marketing services held 37.20% of the healthcare marketing services market share in 2025, while analytics, insights, and compliance services is projected to expand at a 7.83% CAGR through 2031.
  • By end-user, pharmaceutical and biotechnology companies held 44.80% of the healthcare marketing services market share in 2025, while healthcare providers and health systems are projected to expand at a 7.89% CAGR through 2031.
  • By geography, North America accounted for 46.80% of revenue in 2025, while Asia-Pacific is projected to expand at a 7.91% CAGR through 2031.

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.

Segment Analysis

By Service Type: Analytics and Compliance Gain Strategic Importance

Digital Marketing Services held 37.20% of the healthcare marketing services market share in 2025, making it the largest service category. The segment includes search marketing, programmatic patient targeting, paid social activity, and other digital channels used by pharmaceutical companies and providers. Its scale reflects the need to reach patients and HCPs across channels where performance can be observed and adjusted. Digital work still depends on reliable content, appropriate targeting, and compliant collection of campaign information. Analytics, Insights, and Compliance Services is projected to expand at a 7.83% CAGR from 2026 to 2031, the fastest pace among service types.

The healthcare marketing services market size for analytics, insights, and compliance work is driven by the need to rebuild measurement when pixel-based attribution is limited. Organizations need practical ways to connect media activity with patient inquiries, appointments, HCP engagement, and other permitted outcomes. This includes server-side analytics, secure data handling, consent records, and reporting designed for healthcare clients. Brand Strategy and Creative Services remain important because brand information must work across AI-generated answers, traditional media, and point-of-care settings. Reputation, Public Relations, and Advocacy Services are also becoming more relevant as provider information, patient feedback, and clinical credibility influence digital discovery.

Healthcare Marketing Services Market Share by Service Type, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Healthcare Marketing Services Market Share by Service Type, 2025

By End-User: Pharmaceutical Companies Anchor Demand and Providers Lead Expansion

Pharmaceutical and Biotechnology Companies held 44.80% of revenue in 2025, the largest end-user position in the healthcare marketing services market. Their demand is supported by high per-brand spending and the need to communicate with HCPs and patients under strict promotional rules. These companies use specialist partners for brand planning, medical communications, media, field enablement, and coordinated campaign delivery. Medical Device and Diagnostics Companies also require careful marketing support because product claims and evidence standards differ across markets. Health Insurance Payers and Health Plans are investing in digital member communications, condition management outreach, and preventive engagement.

Healthcare Providers and Health Systems are projected to expand at a 7.89% CAGR from 2026 to 2031, the fastest end-user rate. Provider organizations are increasing their work on patient acquisition, online scheduling, service-line communications, and local reputation. These assignments often require coordination across hospital locations, physician groups, access teams, and technology vendors. Healthcare providers must also manage the privacy implications of website and campaign tools that touch patient data. The healthcare marketing services industry serves this group through digital front-door design, AI search visibility, patient engagement, and compliant measurement services.

Healthcare Marketing Services Market Share by End-User, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Healthcare Marketing Services Market Share by End-User, 2025

Geography Analysis

North America accounted for 46.80% of the healthcare marketing services market share in 2025. The region has substantial pharmaceutical promotion, an established healthcare advertising infrastructure, and early adoption of healthcare-focused AI tools. US enforcement activity has also made privacy-safe data practices central to agency selection. The Federal Trade Commission’s July 2026 action against Hims and Hers highlighted ongoing scrutiny of the use of sensitive health information in advertising systems. Agencies that can meet privacy, FDA-awareness, and healthcare data requirements have an advantage over general digital marketing firms.

Asia-Pacific is projected to expand at a 7.91% CAGR from 2026 to 2031, the fastest regional rate. Growth reflects pharmaceutical expansion, digital health investment, mobile-first care behavior, and increasing demand for patient engagement tools. India’s digital health programs have created important infrastructure for broader healthcare digitization. China’s healthcare platforms are supporting AI-enabled chronic disease management and new forms of pharmaceutical engagement. Japan and South Korea require market-specific data protection approaches, which adds complexity for international agencies. The healthcare marketing services market size in Asia-Pacific is therefore shaped by both commercial expansion and differing local data rules.

Europe is implementing the European Health Data Space framework, which entered into force in 2025 and sets a common approach to health data access and use across the European Union.[3]European Union, “Regulation (EU) 2025/327 on the European Health Data Space,” Official Journal of the European Union, eur-lex.europa.eu France updated its national digital health doctrine in 2026 to reflect the European Health Data Space requirements and AI ethics for the use of health data. South America has an emerging digital health ecosystem, with Brazil providing a large share of the region’s health technology activity. Demand in the Middle East and Africa is driven by competition among private hospitals in Saudi Arabia and the United Arab Emirates, as well as pharmaceutical expansion in major African cities.

Healthcare Marketing Services Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The healthcare marketing services market is moderately fragmented globally, with large holding companies competing alongside healthcare-focused data and commercialization specialists. Omnicom Group, Publicis Groupe, WPP, and Havas Health Network compete for major pharmaceutical and health system accounts. Indegene, Real Chemistry, IQVIA, EVERSANA, and Syneos Health provide specialist capabilities that combine communications, commercial analytics, and healthcare data. Omnicom completed its acquisition of Interpublic Group on November 26, 2025.[4]Omnicom, “Omnicom Announces Strategy and Executive Leadership Following Acquisition of Interpublic,” Omnicom, omc.com The transaction expanded Omnicom’s healthcare network and increased the importance of integration across agency brands and data assets.

In April 2026, Omnicom Health rebranded FCB Health New York as Olixir New York. The move connected the business with Omnicom’s life sciences data and AI platform, according to the company. Indegene acquired BioPharm in October 2025 to add AdTech and data-driven omnichannel capabilities to its commercialization portfolio. In February 2026, Havas Health and BrightInsight formed a global partnership on digital medication persistence and adherence solutions. These actions show that competition is expanding beyond campaign execution toward data, patient support, and regulated digital infrastructure.

Syneos Health expanded strategic AI partnerships in May 2026 around its Mindset Engine behavioral intelligence system. Real Chemistry established an Asia-Pacific hub through its acquisition of Spurwing Communications in Singapore in July 2026. Firms that combine clinical understanding, consented data practices, and measurable patient or HCP engagement can differentiate their offers. Generative AI places commodity content under pressure and shifts higher-value work toward compliant measurement, AI visibility, approved-content workflows, and ongoing patient engagement programs.

Leaders of Healthcare Marketing Services

  1. Omnicom Group Inc.

  2. Publicis Groupe S.A.

  3. WPP plc

  4. Havas Health Network

  5. Real Chemistry, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Healthcare Marketing Services Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Recent Industry Developments

  • July 2026: The FTC, joined by the states of Utah and California, filed suit against telehealth provider Hims and Hers, alleging that the company shared consumers’ sensitive health data, including medical conditions, with advertising platforms Meta and Snap via tracking pixels, despite explicit patient privacy commitments. The complaint marks a formal escalation of federal-state enforcement cooperation on health data privacy in marketing contexts.
  • July 2026: Real Chemistry established its first Asia-Pacific strategic hub by acquiring Spurwing Communications in Singapore. The acquisition brings integrated communications and medical affairs capabilities serving pharmaceutical and healthcare organizations across the Asia-Pacific region, directly supporting growth in the fastest-expanding geographic market.
  • May 2026: Swoop, an AI-driven healthcare patient engagement platform, acquired Nimble, a prescription management platform operating in all 50 US states. The acquisition connects Swoop’s privacy-safe audience targeting with pharmacy-level prescription-fulfillment data, enabling life sciences clients to trace their marketing investment directly to therapy initiation.
  • May 2026: Syneos Health announced expanded strategic AI partnerships to advance commercial precision performance, built around its Mindset Engine behavioral intelligence system spanning nearly 14,000 HCPs across more than 30 specialties. The expansion deepens the company’s competitive position as holding companies integrate AI at the network level.

Table of Contents for Report on Healthcare Marketing Services

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise of Patient Self-Navigation Across Search, Social, and AI
    • 4.2.2 Expansion of Digital Front Door and Online Scheduling Investment
    • 4.2.3 Growth of Omnichannel Commercialization and Personalization Programs
    • 4.2.4 Intensifying Reputation Management and Review-driven Patient Choice
    • 4.2.5 Generative Engine Optimization and AI Directory Visibility Spend
    • 4.2.6 Telemedicine Advertising Liberalization in Select Regulated Markets
  • 4.3 Market Restraints
    • 4.3.1 Privacy Litigation Around Tracking Pixels and Consent
    • 4.3.2 Fragmented Data and Slow Medical, Legal, and Regulatory Review Cycles
    • 4.3.3 Zero-click Search Erodes Traditional SEO Economics
    • 4.3.4 Platform Certification and Content-policy Volatility
  • 4.4 Impact of Macroeconomic Factors on the Market
  • 4.5 Industry Value Chain Analysis
  • 4.6 Regulatory Landscape
  • 4.7 Technological Outlook
  • 4.8 Porter's Five Forces Analysis
    • 4.8.1 Bargaining Power of Buyers
    • 4.8.2 Bargaining Power of Suppliers
    • 4.8.3 Threat of New Entrants
    • 4.8.4 Threat of Substitutes
    • 4.8.5 Intensity of Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Service Type
    • 5.1.1 Digital Marketing Services
    • 5.1.2 Brand Strategy and Creative Services
    • 5.1.3 Reputation, Public Relations, and Advocacy Services
    • 5.1.4 Analytics, Insights, and Compliance Services
  • 5.2 By End-User
    • 5.2.1 Healthcare Providers and Health Systems
    • 5.2.2 Pharmaceutical and Biotechnology Companies
    • 5.2.3 Medical Device and Diagnostics Companies
    • 5.2.4 Health Insurance Payers and Health Plans
  • 5.3 By Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 South America
    • 5.3.2.1 Brazil
    • 5.3.2.2 Argentina
    • 5.3.2.3 Chile
    • 5.3.2.4 Rest of South America
    • 5.3.3 Europe
    • 5.3.3.1 Germany
    • 5.3.3.2 United Kingdom
    • 5.3.3.3 France
    • 5.3.3.4 Italy
    • 5.3.3.5 Spain
    • 5.3.3.6 Netherlands
    • 5.3.3.7 Russia
    • 5.3.3.8 Rest of Europe
    • 5.3.4 Asia-Pacific
    • 5.3.4.1 China
    • 5.3.4.2 Japan
    • 5.3.4.3 India
    • 5.3.4.4 Australia
    • 5.3.4.5 South Korea
    • 5.3.4.6 Singapore
    • 5.3.4.7 Rest of Asia-Pacific
    • 5.3.5 Middle East
    • 5.3.5.1 Saudi Arabia
    • 5.3.5.2 United Arab Emirates
    • 5.3.5.3 Turkey
    • 5.3.5.4 Israel
    • 5.3.5.5 Rest of Middle East
    • 5.3.6 Africa
    • 5.3.6.1 South Africa
    • 5.3.6.2 Egypt
    • 5.3.6.3 Nigeria
    • 5.3.6.4 Kenya
    • 5.3.6.5 Rest of Africa

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Share Analysis
  • 6.4 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
    • 6.4.1 Omnicom Group Inc.
    • 6.4.2 Publicis Groupe S.A.
    • 6.4.3 WPP plc
    • 6.4.4 Havas Health & You
    • 6.4.5 Indegene Limited
    • 6.4.6 Real Chemistry, Inc.
    • 6.4.7 IQVIA Inc.
    • 6.4.8 Accenture plc
    • 6.4.9 Klick Inc.
    • 6.4.10 Avalere Health Topco Limited
    • 6.4.11 OPEN Health Communications LLP
    • 6.4.12 Merkle Inc.
    • 6.4.13 Syneos Health, Inc.
    • 6.4.14 Cognizant Technology Solutions Corporation
    • 6.4.15 EVERSANA, LLC
    • 6.4.16 GCI Health, LLC
    • 6.4.17 Experian plc
    • 6.4.18 PatientPoint, LLC
    • 6.4.19 CMI Media Group

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

  • 7.1 White-Space and Unmet-Need Assessment

Scope of Report on Healthcare Marketing Services

The Healthcare Marketing Services Market comprises revenue generated from professional marketing, communication, branding, and patient engagement services provided to organizations across the healthcare ecosystem. These services are designed to help healthcare organizations strengthen brand positioning, improve patient and customer engagement, enhance market awareness, support product commercialization, and drive business growth while complying with healthcare regulations and industry standards.

The Healthcare Marketing Services Market Report is Segmented by Service Type (Digital Marketing Services, Brand Strategy and Creative Services, Reputation, Public Relations, and Advocacy Services, and Analytics, Insights, and Compliance Services), End-User (Healthcare Providers and Health Systems, Pharmaceutical and Biotechnology Companies, Medical Device and Diagnostics Companies, and Health Insurance Payers and Health Plans), and Geography (North America, South America, Europe, Asia-Pacific, Middle East, and Africa). The Market Forecasts are Provided in Terms of Value (USD).

By Service Type
Digital Marketing Services
Brand Strategy and Creative Services
Reputation, Public Relations, and Advocacy Services
Analytics, Insights, and Compliance Services
By End-User
Healthcare Providers and Health Systems
Pharmaceutical and Biotechnology Companies
Medical Device and Diagnostics Companies
Health Insurance Payers and Health Plans
By Geography
North AmericaUnited States
Canada
Mexico
South AmericaBrazil
Argentina
Chile
Rest of South America
EuropeGermany
United Kingdom
France
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia-PacificChina
Japan
India
Australia
South Korea
Singapore
Rest of Asia-Pacific
Middle EastSaudi Arabia
United Arab Emirates
Turkey
Israel
Rest of Middle East
AfricaSouth Africa
Egypt
Nigeria
Kenya
Rest of Africa
By Service TypeDigital Marketing Services
Brand Strategy and Creative Services
Reputation, Public Relations, and Advocacy Services
Analytics, Insights, and Compliance Services
By End-UserHealthcare Providers and Health Systems
Pharmaceutical and Biotechnology Companies
Medical Device and Diagnostics Companies
Health Insurance Payers and Health Plans
By GeographyNorth AmericaUnited States
Canada
Mexico
South AmericaBrazil
Argentina
Chile
Rest of South America
EuropeGermany
United Kingdom
France
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia-PacificChina
Japan
India
Australia
South Korea
Singapore
Rest of Asia-Pacific
Middle EastSaudi Arabia
United Arab Emirates
Turkey
Israel
Rest of Middle East
AfricaSouth Africa
Egypt
Nigeria
Kenya
Rest of Africa

Key Questions Answered in the Report

What is the healthcare marketing services market size?

The healthcare marketing services market was valued at USD 56.82 billion in 2026 and is projected to reach USD 79.81 billion by 2031 at a 7.03% CAGR.

What is driving demand for healthcare marketing services?

Demand is supported by digital patient navigation, appointment access systems, coordinated pharmaceutical communications, and the need for compliant measurement.

Which service category held the largest revenue share?

Digital Marketing Services held the largest share at 37.20% in 2025, supported by pharmaceutical and provider investment in digital outreach.

Which end-user group is projected to expand fastest?

Healthcare Providers and Health Systems are projected to expand at a 7.89% CAGR through 2031 as they invest in patient acquisition and digital access.

Which region is projected to expand fastest?

Asia-Pacific is projected to expand at a 7.91% CAGR through 2031, supported by digital health investment and pharmaceutical commercial expansion.

Why is privacy compliance important for healthcare marketing?

Privacy requirements affect analytics, advertising pixels, consent practices, and the ability to connect marketing activity with healthcare outcomes.

Page last updated on: